摘要:
A system for making a precise incision and circular hole in a vessel wall, such as the aorta, that eliminates lateral side notches from the aortotomy. In one aspect, the system includes a surgical knife or lancet having a blade surrounded by a retractable shield. In one aspect, the system includes a tissue punch having a rotating circumferential edge for receiving a parabolic-shaped anvil having an anvil cutting edge. The anvil is placed through an incision made by a knife and actuated to produce a hole in the vessel wall.
摘要:
Described are devices, methods, and systems for grafting tissues or organs that are exposed to bacterial or mammalian enzymes that degrade collagenous materials. Illustrative medical grafts are processed by contacting a collagenous extracellular matrix (ECM) material with a mono-carboxylic acid having from four to about twelve carbon atoms, or mixtures of two or more such acids.
摘要:
Described are packaged, sterile medical graft products containing controlled levels of a growth factor such as Fibrob-last Growth Factor-2 (FGF-2). Also described are methods of manufacturing medical graft products wherein processing, including sterilization, is controlled and monitored to provide medical graft products having modulated, known levels of a extracellular matrix factor, such as a growth factor, e.g. FGF-2. Preferred graft materials are extracellular matrix materials isolated from human or animal donors, particularly submucosa containing extracellular matrix materials. Further described are ECM compositions that are or are useful for preparing gels, and related methods for preparation and use.
摘要:
Apparatus and methods for segmenting television audience data are disclosed. The methods include receiving program level viewing data for one or more individuals. The methods also include creating one or more segments for the one or more individuals based upon the program level viewing data. The methods further include combining the one or more segments into one or more groups by applying a grouping function and performing analysis on the one or more groups, and generating reports based upon the analysis.
摘要:
Described are packaged, sterile medical graft products containing controlled levels of a growth factor such as Fibroblast Growth Factor-2 (FGF-2). Also described are methods of manufacturing medical graft products wherein processing, including sterilization, is controlled and monitored to provide medical graft products having modulated, known levels of a extracellular matrix factor, such as a growth factor, e.g. FGF-2. Preferred graft materials are extracellular matrix materials isolated from human or animal donors, particularly submucosa-containing extracellular matrix materials. Further described are ECM compositions that are or are useful for preparing gels, and related methods for preparation and use.